Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Diabetes

Why Hims & Hers Health Shares Are Sliding Friday

Shares of Hims Hers Health Inc (NYSE:HIMS) are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. Here’s what investors need to know.

Benzinga

Could Sitting All Day Be as Harmful as Smoking? A Top Wellness Coach Shares Their Take

Stuck in the bed to desk to sofa cycle? We've all been there, and here's how to change it.

Marie Claire

California to begin selling affordable state-branded insulin beginning next year

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Obesity remains high in the US, but more states are showing progress, a new report finds

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped

The Independent UK

Some good news on obesity — but with major caveats

The number of states with an extremely high obesity rate dropped but remains historically high.

Axios

Huge demand for popular new drug behind long NHS waiting lists

Some groups are waiting more than a year for crucial exams

The Independent UK

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shared details on Tuesday about its pivotal Phase 3 program of Duravyu (vorolanib intravitreal insert) for diabetic macular edema (DME) and began first patient dosing, anticipated in the first quarter of 2026.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Almost 70% of US adults would be deemed obese based on new definition, study finds

Medical experts have called for new way to more accurately measure obesity, although definition has yet to be adopted

The Guardian - UK

Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations

Abbott Laboratories (NYSE:ABT) stock fell after the company reported muted sales in the third quarter and narrowed fiscal 2025 guidance.

Benzinga

Always Hungry or Noticing Energy Crashes? You Might Be Eating Too Much Hidden Sugar - 7 Tell-Tale Signs

Sugar can definitely be enjoyed as part of a balanced diet - but consume too much, and there are some clear health implications.

Marie Claire

UK weight loss jab sales increase sevenfold to 2.5 million, new figures show

Health secretary Wes Streeting wants to make the drugs more widely available on the NHS

The Independent UK

French consumer group sounds alarm on sugary, ultra processed dairy products for children

A French consumer watchdog has slammed ten popular children’s dairy products, warning they’re overloaded with sugar, salt, fat, and ultra-processed ingredients, putting young consumers’ health at serious risk.

Radio France Internationale

New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests

GLP-1 drugs may interfere with medical imaging, leading to unnecessary tests, researchers have found

The Independent UK

Costco to start selling Ozempic and Wegovy at discounted prices

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Childhood Obesity: How Parents Can Help Their Kids Who Are Overweight

Learn how to help your child who is experiencing being overweight and avoid getting into obesity.

Fit & Well

If I wanted to improve my peri- and menopause symptoms I’d follow this expert’s dietary advice

How fiber could be your secret weapon for managing menopause

Evening Standard

Ban on 'buy one, get one free' deals on unhealthy foods comes into place

The UK Government is implementing a ban on the promotion of unhealthy foods as part of a broader health initiative.

The Independent UK

Weight-loss jabs should be available to millions more on NHS, Streeting suggests

Health should not be determined by wealth, says Wes Streeting at the Labour Party conference

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Why you might actually be healthier if you put on weight

A new study has linked higher mortality rates with people in the middle and lower end of the normal weight range

AAP

Easier access to prescriptions as nurses' powers grow

Qualified nurses will help alleviate the burdens on the health system by providing patients with another avenue for their prescriptions.

Benzinga

Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch

On Wednesday, Eli Lilly Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

Evening Standard

DNA test reveals which weight loss drug could work best for you

With a growing number of people turning to weight loss drugs, a new study suggests that some weight loss drugs work better than others depending on your DNA.

The Independent UK

Scientists surprised to find human body makes its own Ozempic version

Study finds body’s ‘built-in backup plan’ for diabetes-controlling hormone production

Axios

Trump to link autism to Tylenol use during pregnancy

The mention of a connection would revive a medical controversy over the use of acetaminophen early in a pregnancy.

Benzinga

Could This New Drug Be The Safer Way To Fight Obesity?

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.